MIRTAZAPINE LOADED PRONANOMICELLES: PREPARATION AND CHARACTERIZATION
DOI:
https://doi.org/10.22159/ijap.2026v18i1.56474Keywords:
Mirtazapine, Nanomicelles, Thin-film hydration method, Soluplus®, Solutol HS 15Abstract
Objective: The aim of this work was to prepare mirtazapine-loaded self-assembled micelles using soluplus®, solutol®HS15 and TPGs to enhance mirtazapine solubility and thus oral bioavailability.
Methods: MTZ nanomicelles were produced by the thin-film hydration method using different polymers in different ratios to prepare stable MTZ nanomicelles, where the soluplus® nanomicelles formula in different ratios was F1 to F4; soluplus® in combination with TPGS to stabilize the nanomicelles formula was formulated in different ratios as in F5 to F10; and soluplus® in combination with SolutolHS 15 as in F10 to F14. The most stable formula is further investigated with particle size, polydispersity index, drug loading, entrapment efficacy, and in vitro release, and then the selected formula is statistically further investigated with FTIR, DSC, and FESEM.
Results: The particle size of the prepared formula ranged from 57 nm for F4 (1:10 of MTZ: soluplus®) to 78 nm for F8 (1:8:4 of MTZ: soluplus®: TPGS); the EE% ranged from 85% to 90%; FTIR analysis suggested no chemical interaction; FESEM showed spherical nanomicelles in Nano size; and DSC showed the transition of the drug to an amorphous form due to MTZ entrapment with in nanomicelles.
Conclusion: Mirtazapine-loaded Soluplus® micelles alone and in combination, first with TPGS and second with Solutol HS 15 by the thin-film hydration method show uniform distribution of particle size, PDI, and enhancement in the in vitro release of the drug.
References
1. Hatamipour M, Sahebkar A, Alavizadeh SH, Dorri M, Jaafari MR. Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids. Iran J Basic Med Sci. 2019;22(3):282-9. doi: 10.22038/ijbms.2019.32873.7852, PMID 31156789.
2. Ezealisiji KE, Mbah CJ, Osadebe PO. Aqueous solubility enhancement of mirtazapine: effect of cosolvent and surfactant. Phamacology Pharmacy. 2015;6(10):471-6. doi: 10.4236/pp.2015.610049.
3. Ghalehkhondabi V, Soleymani M, Fazlali A. Folate-targeted nanomicelles containing silibinin as an active drug delivery system for liver cancer therapy. J Drug Deliv Sci Technol. 2021 Aug;61:102157. doi: 10.1016/j.jddst.2020.102157.
4. Mohamed S, Parayath NN, Taurin S, Greish K. Polymeric nano-micelles: versatile platform for targeted delivery in cancer. Ther Deliv. 2014;5(10):1101-21. doi: 10.4155/tde.14.69, PMID 25418269.
5. Razif MR, Chan SY, Widodo RT, Chew YL, Hassan M, Hisham SA. Optimization of a luteolin-loaded TPGS/Poloxamer 407 nanomicelle: the effects of copolymers hydration temperature and duration and freezing temperature on encapsulation efficiency particle size and solubility. Cancers (Basel). 2023;15(14):3741. doi: 10.3390/cancers15143741.
6. Pignatello R, Corsaro R, Bonaccorso A, Zingale E, Carbone C, Musumeci T. Soluplus® polymeric nanomicelles improve solubility of BCS-class II drugs. Drug Deliv Transl Res. 2022;12(8):1991-2006. doi: 10.1007/s13346-022-01182-x, PMID 35604634.
7. Shelake PR, Shah RR, Nalawade VV, Majalekar PP. Formulation and evaluation of solid self-emulsifying drug delivery system for drug mirtazapine. Int J Pharm Sci Res. 2019;10(10):934. doi: 10.13040/IJPSR.0975-8232.10.
8. Hamed HE, Hussein AA. Preparation in vitro and ex-vivo evaluation of mirtazapine nanosuspension and nanoparticles incorporated in orodispersible tablets. Iraqi J Pharm Sci. 2020;29(1):62-75. doi: 10.31351/vol29iss1pp62-75.
9. Aldeeb RA, Mahdy MA, El Nahas HM, Musallam AA. Design of mirtazapine solid dispersion with different carriers systems: optimization in vitro evaluation and bioavailability assessment. Drug Deliv Transl Res. 2023;13(9):2340-52. doi: 10.1007/s13346-023-01316-9, PMID 36940079.
10. Sulaiman HT, Rajab NA. Preparation and characterization of olmesartan medoxomil-loaded polymeric mixed micelle nanocarrier. Iraqi J Pharm Sci. 2024;33(4SI):89-100. doi: 10.31351/vol33iss(4SI)pp89‑100.
11. Jassem NA, Abd Alhammid SN. Formulation and evaluation of canagliflozin self-nanomicellizing solid dispersion based on rebaudioside a for dissolution and solubility improvement. Iraqi J Pharm Sci. 2024;33(4SI):43-56. doi: 10.31351/vol33iss(4SI)pp43‑56.
12. Al wiswasi NN, Al Gawahri FJ. Brimonidine soluplus nanomicelles: preparation and in vitro evaluation. Iraqi J Pharm Sci. 2025;34(1):246-55. doi: 10.31351/vol34iss1pp246-255.
13. Mohammed AA. Preparation in vitro evaluation and characterization studies of clozapine nanosuspension. 2025;33(4SI):336-48. doi: 10.31351/vol33iss(4SI)pp336‑348.
14. Rashid AM, Ghareeb MM. Using ionic liquid-based surfactant in formulating nimodipine polymeric nanoparticles: a promising approach for improved performance. Iraqi J Pharm Sci. 2025;34(1):203-17. doi: 10.31351/vol34iss1pp203-217.
15. Al Edhari GH, Al Gawhari FJ. Study the effect of formulation variables on preparation of nisoldipine-loaded nano bilosomes. IJPS. 2023;32Suppl:271-82. doi: 10.31351/vol32issSuppl.pp271-282.
16. Radhi AA, Ali WK, Al Saedi F. Preparation and in vitro evaluation of synthetic high-density lipoproteins as parenteral drug delivery system for tamoxifen citrate. IJPS. 2023;32(3):105-17. doi: 10.31351/vol32iss3pp105-117.
17. Keshari P, Sonar Y, Mahajan H. Curcumin-loaded TPGS micelles for nose-to-brain drug delivery: in vitro and in vivo studies. Mater Tech Internet. 2019;34(7):423-32. doi: 10.1080/10667857.2019.1575535.
18. El Helaly SN, Rashad AA. Mirtazapine loaded polymeric micelles for rapid-release tablet: a novel formulation-in vitro and in vivo studies. Drug Deliv Transl Res. 2024;14(9):2488-98. doi: 10.1007/s13346-024-01525-w, PMID 38353837.
19. Rashid AM, Abdal Hammid SN. Formulation and characterization of itraconazole as nanosuspension dosage form for enhancement of solubility. Iraqi J Pharm Sci. 2019;28(2):124-33. doi: 10.31351/vol28iss2pp124-133.
20. Abdulqader AA, Sultan NA. Preparation and characterization of posaconazole as a nano-micelles using d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Iraqi J Pharm Sci. 2023;32Suppl:26-32. doi: 10.31351/vol32issSuppl.pp26-32.
21. Salih O, Muhammed E. Preparation, evaluation and histopathological studies of ondansetron‑loaded invasomes transdermal gel. J Res Pharm. 2024;28(1):289–303. doi: 10.29228/jrp.696.
22. Salih OS, Hamoddi ZM, Taher SS. Development and characterization of controlled release tablets of candesartan cilexetil/ β cyclodextrin inclusion complex. Int J Drug Deliv Technol. 2020;10(2):273-83. doi: 10.25258/ijddt.10.2.15.
23. De Groat W, Abdelhalim H, Patel K, Mendhe D, Zeeshan S, Ahmed Z. Discovering biomarkers associated and predicting cardiovascular disease with high accuracy using a novel nexus of machine learning techniques for precision medicine. Sci Rep. 2024;14(1):1. doi: 10.1038/s41598-023-50600-8, PMID 38167627.
24. Arukkunakorn W, Sajomsang W, Ovatlarnporn C. Resveratrol enhance loading capacity and solubility of dimethylcurcumin in pluronic f-127 nanomicelles. Eur Chem Bull; 2023 July.
25. Nalinbenjapun S, Sripetthong S, Basit A, Suksuwan A, Sajomsang W, Ovatlarnporn C. Fabrication of curcumin-loaded nano-micelles based on quercetin-quarternary ammonium-chitosan (Qu-QCS) conjugate and evaluation of synergistic effect with doxorubicin against breast cancer. Int J Biol Macromol. 2024;281(2):135904. doi: 10.1016/j.ijbiomac.2024.135904, PMID 39482127.
26. Brandao FC, Tagiari MP, Silva MA, Berti LF, Stulzer HK. Physical-chemical characterization and quality control of spironolactone raw material samples. Pharm Chem J. 2008;42(6):368-76. doi: 10.1007/s11094-008-0129-3.
27. Piazzini V, D Ambrosio M, Luceri C, Cinci L, Landucci E, Bilia AR. Formulation of nanomicelles to improve the solubility and the oral absorption of silymarin. Molecules. 2019;24(9):1688. doi: 10.3390/molecules24091688, PMID 31052197.
28. Ali R, Qamar W, Kalam MA, Binkhathlan Z. Soluplus-TPGS mixed micelles as a delivery system for brigatinib: characterization and in vitro evaluation. ACS Omega. 2024;9(40):41830-40. doi: 10.1021/acsomega.4c06264, PMID 39398132.
29. Miyazawa T, Itaya M, Burdeos GC, Nakagawa K, Miyazawa T. A critical review of the use of surfactant-coated nanoparticles in nanomedicine and food nanotechnology. Int J Nanomedicine. 2021;16:3937-99. doi: 10.2147/IJN.S298606, PMID 34140768.
30. Shakiba E, Khazaei S, Hajialyani M, Astinchap B, Fattahi A. Preparation and in vitro characterization of retinoic acid-loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) micelles. Res Pharm Sci. 2017;12(6):465-78. doi: 10.4103/1735-5362.217427, PMID 29204175.
31. Musallam AA, Mahdy MA, Elnahas HM, Aldeeb RA. Optimization of mirtazapine loaded into mesoporous silica nanostructures via box-behnken design: in vitro characterization and in vivo assessment. Drug Deliv. 2022;29(1):1582-94. doi: 10.1080/10717544.2022.2075985, PMID 35612286.
32. Circioban D, Ledeți A, Ridichie A, Vlase T, Ledeți I, Bradu IA. Compatibility study of mirtazapine with several excipients used in pharmaceutical dosage forms employing thermal and non-thermal methods. J Therm Anal Calorim. 2024;150(9):6747-59. doi: 10.1007/s10973-024-13181-w.
33. Alwan RM, Rajab NA. Nanosuspensions of selexipag: formulation characterization and in vitro evaluation. Iraqi J Pharm Sci. 2021;30(1):144-53. doi: 10.31351/vol30iss1pp144-153.
34. Lan Y, Ali S, Langley N. Characterization of Soluplus® by FTIR and raman spectroscopy. In: Proceedings of the CRS 2010 Annual Conference; 2010 Oct. p. 1138.
35. Naresh WR, Dilip DV, Sunil KP. Xyloglucan-based nasal in situ gel formulation of mirtazapine for treatment of depression. Indian J Pharm Educ Res. 2020;54(2 Suppl):S210-9. doi: 10.5530/ijper.54.2s.77.
36. Pawar JN, Shete RT, Gangurde AB, Moravkar KK, Javeer SD, Jaiswar DR. Development of amorphous dispersions of artemether with hydrophilic polymers via spray drying: physicochemical and in silico studies. Asian J Pharm Sci. 2016;11(3):385-95. doi: 10.1016/j.ajps.2015.08.012.
37. Shamma RN, Basha M. Soluplus®: a novel polymeric solubilizer for optimization of carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol. 2013;237:406-14. doi: 10.1016/j.powtec.2012.12.038.
38. Marimuthu A, Seenivasan R, Pachiyappan JK, Nizam I, Ganesh G. Synergy of science and tradition: a nanotechnology-driven revolution in natural medicine. Int J App Pharm. 2024;16(6):10-20. doi: 10.22159/ijap.2024v16i6.50767.
39. Nafis FDR, Sriwidodo, Chaerunisaa AY. Study on increasing solubility of isolates: methods and enhancement polymers. Int J Appl Pharm. 2022;14(6):6-13. doi: 10.22159/ijap.2022v14i6.45975.
40. Alkufi HK, Kassab HJ. Soluplus stabilized nimodipine entrapped Spanlastic formulations prepared with edge activator (Tween20): comparative physicochemical evaluation. Pharm Nanotechnol. 2024;13(3):551-63. doi: 10.2174/0122117385348551241028102256, PMID 39501952.
41. Alkufi HK, Kassab HJ. Nanospanlastic in situ gel for nose to brain delivery of nimodipine: in vitro optimization and in vivo pharmacokinetic study. Al Rafidain J Med Sci. 2025;8(1):97-105. doi: 10.54133/ajms.v8i1.1687.
42. Guembe Michel N, Nguewa P, Gonzalez Gaitano G. Soluplus®-based pharmaceutical formulations: recent advances in drug delivery and biomedical applications. Int J Mol Sci. 2025;26(4):1499. doi: 10.3390/ijms26041499, PMID 40003966.
Published
How to Cite
Issue
Section
Copyright (c) 2026 ahmed ibrahim, Nawal Ayash
This work is licensed under a Creative Commons Attribution 4.0 International License.